Relief of symptoms in end-stage neurological conditions.
Effective multidisciplinary team working is essential to manage neurological symptoms as end of life approaches. Coordination of care ensures timely input of specialist therapies, pharmacological measures and occasionally invasive techniques including surgery. This can impact not only on function but also aid passive care and comfort.
Stevenson
Valerie L
VL
National Hospital for Neurology and Neurosurgery, London.
D001418:Baclofen / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D003072:Cognition Disorders / Q000209:etiology / Q000628:therapy; D003680:Deglutition Disorders / Q000209:etiology / Q000628:therapy; D006801:Humans; D019964:Mood Disorders / Q000209:etiology / Q000628:therapy; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009128:Muscle Spasticity / Q000628:therapy; D009422:Nervous System Diseases / Q000150:complications / Q000628:therapy*; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D010636:Phenols / Q000627:therapeutic use; D012002:Rectal Diseases / Q000209:etiology / Q000628:therapy; D012120:Respiration Disorders / Q000209:etiology / Q000628:therapy; D013064:Speech Disorders / Q000209:etiology / Q000628:therapy; D013727:Terminal Care / Q000379:methods*; D019452:Terminally Ill; D001745:Urinary Bladder Diseases / Q000209:etiology / Q000628:therapy
D009125:Muscle Relaxants, Central; D010636:Phenols; D001418:Baclofen